Review: Noncomplete Mesorectal Excision Up With Laparoscopy

Share this content:
Review: Noncomplete Mesorectal Excision Up With Laparoscopy
Review: Noncomplete Mesorectal Excision Up With Laparoscopy

FRIDAY, Feb. 10, 2017 (HealthDay News) -- Patients undergoing laparoscopic rectal resection (LRR) have increased risk for noncomplete mesorectal excision versus those undergoing open rectal resection (ORR), according to a review and meta-analysis published online Feb. 8 in JAMA Surgery.

Aleix Martínez-Pérez, M.D., from the Henri Mondor University Hospital in Paris, and colleagues conducted a systematic review of randomized clinical trials (RCTs) that compared LRR with ORR for histologically proven rectal cancer in adult patients. Data were included for 14 RCTs with 4,034 unique patients.

Of the 2,989 patients undergoing rectal resection, the researchers identified a positive circumferential resection margin in 7.9 and 6.1 percent of the 1,697 and 1,292 patients undergoing LRR and ORR, respectively (risk ratio, 1.17; 95 percent confidence interval, 0.89 to 1.53; P = 0.26) in nine studies. In five studies, a noncomplete (nearly complete and incomplete) mesorectal excision occurred in 13.2 and 10.4 percent of 1,354 patients undergoing LRR and the 998 patients undergoing ORR, respectively (risk ratio, 1.31; 95 percent confidence interval, 1.05 to 1.64; P = 0.02). There was no significant difference between LRR and ORR in the distal resection margin involvement, the mean number of lymph nodes retrieved, the mean distance to the distal margin, and the mean distance to radial margins.

"These findings question the oncologic safety of laparoscopy for the treatment of rectal cancer," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »